Vildagliptin, type 2 diabetes, gastric emptying
Showing 1 - 25 of >10,000
Type 2 Diabetes Trial (Acetaminophen/SHR20004, Acetaminophen/Placebo)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Acetaminophen/SHR20004
- Acetaminophen/Placebo
- (no location specified)
Nov 17, 2023
Type 2 Diabetes Trial in Damanhur (Vildagliptin 50 MG, Glimepiride 3 Mg Oral Tablet)
Recruiting
- Type 2 Diabetes
- Vildagliptin 50 MG
- Glimepiride 3 Mg Oral Tablet
-
Damanhūr, Elbehairah, EgyptDamanhour Teaching Hospital, General Organization for Teaching H
Sep 29, 2023
Glucotoxicity on Gastric Emptying in Chinese Newly Diagnosed
Active, not recruiting
- Type 2 Diabetes
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Mar 16, 2022
Gastric Emptying - Implications for Pathogenesis of Type 2
Recruiting
- Diabetes Mellitus, Type 2
-
Nottingham, Notts, United KingdomDavid Greenfield Human Physiology Unit, University of Nottingham
Apr 5, 2022
Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)
Completed
- Type 2 Diabetes
-
Karachi, Sindh, PakistanDepartment of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022
Diabetes, Type 1, Diabetes, Type 2, Functional Dyspepsia Trial in Ostrava, Prague
Recruiting
- Diabetes Mellitus, Type 1
- +4 more
-
Ostrava, Czechia
- +1 more
Oct 3, 2023
Type 2 Diabetes, Morbid Obesity, Bariatric Surgery Trial in Patras (Laparoscopic Roux en Y gastric bypass, Laparoscopic Roux en
Completed
- Type 2 Diabetes
- +2 more
- Laparoscopic Roux en Y gastric bypass
- Laparoscopic Roux en Y gastric bypass with fundus resection
-
Patras, Rio, GreeceUniversity of Patras, University Hospital of Patras
May 2, 2023
Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
-
Al Ain, Abu Dhabi, United Arab EmiratesInternal Medicine, College of Medicine and Health Sciences
Mar 1, 2023
Severe Obesity, Diabetes, Type 2, Bariatric Surgery Candidate Trial in L'Hospitalet De Llobregat (Duodenal Switch, SADI-S,
Enrolling by invitation
- Severe Obesity
- +2 more
- Duodenal Switch
- +2 more
-
L'Hospitalet De Llobregat, Barcelona, SpainHospital Universitari de Bellvitge
Sep 12, 2023
Diabetes, Type 2 Trial in Shinjuku-Ku (Imeglimin, Metformin, Vildagliptin)
Recruiting
- Diabetes Mellitus, Type 2
- Imeglimin
- +2 more
-
Shinjuku-Ku, Tokyo, JapanCenter Hospital of the National Center for Global Health and Med
Sep 26, 2022
Extremely Obese Patients Undergoing Gastric Sleeve Surgery
Active, not recruiting
- Obesity, Morbid
- +2 more
-
Pécs, HungarySiptár Miklós
Jun 30, 2023
Type 2 Diabetes, Morbid Obesity Trial in Tønsberg (Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy,
Active, not recruiting
- Type 2 Diabetes
- Morbid Obesity
- Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy
- +2 more
-
Tønsberg, Vestfold, NorwayThe Morbid Obesity Center, Vestfold Hospital Trust
Jun 1, 2022
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)
Completed
- Type II Diabetes in Subjects BMI 27 to 32
- Roux-en-Y Gastric Bypass (RYGB)
- +4 more
-
Singapore, SingaporeKhoo Teck Puat Hospital
Jun 22, 2022
Metformin and DPP4 Inhibitors on Cognition and Cardiovascular
Recruiting
- Type 2 Diabetes Mellitus
-
Cairo, Al Kasr Al Aini, EgyptNational Institute of diabetes and endocrinology
Jun 19, 2022
Type 2 Diabetes, Obesity Trial in Rochester (procedure, behavioral, drug)
Completed
- Type 2 Diabetes Mellitus
- Obesity
- Roux-en-Y Gastric Bypass (RYGB)
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2022
Intestinal Metabolic Reprogramming asKey Mechanism of Gastric
Active, not recruiting
- Obesity
- +4 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital of UPMC
Aug 2, 2022
Systemic Metabolic Rate of Diabetic Patients Before and After
Completed
- Obesity
- Diabetes Mellitus, Type 2
- (no location specified)
Aug 16, 2022
Who Will Benefit From Bariatric Surgery for Diabetes?
Recruiting
- Diabetes Mellitus, Type 2
- Obesity
- Roux-en-Y gastric bypass (RYGB)
-
London, Greater London, United KingdomImperial College Healthcare NHS Trust
Aug 16, 2022
Comorbidities Resolution After MGB Surgery and Change in Body
Not yet recruiting
- Morbid Obesity
- +7 more
- Mini gastric bypass surgery
- (no location specified)
Aug 28, 2023
Gastric Cancer, Diabetes, Type 2 Trial in Seoul (Long limb Roux-en-Y reconstruction after subtotal gastrectomy, Conventional
Recruiting
- Gastric Cancer
- Diabetes Mellitus, Type 2
- Long limb Roux-en-Y reconstruction after subtotal gastrectomy
- +2 more
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Apr 8, 2022
Gastroparesis, Gastroparesis-like Syndrome Trial in United States
Not yet recruiting
- Gastroparesis
- Gastroparesis-like Syndrome
-
Boston, Massachusetts
- +5 more
Aug 1, 2023
Obesity, Type2diabetes, Bariatric Surgery Candidate Trial in Lisboa (Roux-en-Y gastric By-pass (RYGB) surgery, Bariatric
Recruiting
- Obesity
- +3 more
- Roux-en-Y gastric By-pass (RYGB) surgery
- Bariatric Arterial Embolization (BAE) procedure
-
Lisboa, PortugalCruz Vermelha Hospital
May 15, 2023
Stomach Tumor, Diabetes, Type 2 Trial in Daegu (long Roux limb Roux-en-Y reconstruction, long biliopancreatic limb Roux-en-Y
Recruiting
- Stomach Neoplasm
- Diabetes Mellitus, Type 2
- long Roux limb Roux-en-Y reconstruction
- long biliopancreatic limb Roux-en-Y reconstruction
-
Daegu, Korea, Republic ofKyungpook National University Chilgok Hospital
Feb 4, 2022